南方医科大学学报
南方醫科大學學報
남방의과대학학보
JOURNAL OF SOUTHERN MEDICAL UNIVERSITY
2014年
12期
1830-1833
,共4页
陈凯旋%江振洲%陈文华%习保民
陳凱鏇%江振洲%陳文華%習保民
진개선%강진주%진문화%습보민
良性前列腺增生%5α-还原酶抑制剂%丁酸基团
良性前列腺增生%5α-還原酶抑製劑%丁痠基糰
량성전렬선증생%5α-환원매억제제%정산기단
benign prostatic hyperplasia%5α-reductase inhibitors%butyric acid
目的:设计合成苯氧丁酸类非甾体5α-还原酶抑制剂,对其进行活性测试。方法以苯基哌嗪哒嗪酮为骨架,引入苯氧丁酸及不同的取代基,设计8个非甾体5α-还原酶抑制剂。以不同取代的苯基哌嗪为原料,与3,6-二氯哒嗪反应制备相应苯基哌嗪哒嗪酮,再与烷基链长度不同的苯氧丁酸乙酯中间体反应得目标化合物。结果所得目标化合物经1H-NMR、MS确认结构,并以非那雄胺为阳性对照药,对其进行体外活性筛选,有7个化合物具有抑制活性。结论活性测试显示7个目标化合物有一定的5α-还原酶抑制活性,其中,化合物A1和A7的抑制活性较好,在3.3×10-5 mol/L水平的抑制率分别是A1(12.50%)、A7(19.64%)。
目的:設計閤成苯氧丁痠類非甾體5α-還原酶抑製劑,對其進行活性測試。方法以苯基哌嗪噠嗪酮為骨架,引入苯氧丁痠及不同的取代基,設計8箇非甾體5α-還原酶抑製劑。以不同取代的苯基哌嗪為原料,與3,6-二氯噠嗪反應製備相應苯基哌嗪噠嗪酮,再與烷基鏈長度不同的苯氧丁痠乙酯中間體反應得目標化閤物。結果所得目標化閤物經1H-NMR、MS確認結構,併以非那雄胺為暘性對照藥,對其進行體外活性篩選,有7箇化閤物具有抑製活性。結論活性測試顯示7箇目標化閤物有一定的5α-還原酶抑製活性,其中,化閤物A1和A7的抑製活性較好,在3.3×10-5 mol/L水平的抑製率分彆是A1(12.50%)、A7(19.64%)。
목적:설계합성분양정산류비치체5α-환원매억제제,대기진행활성측시。방법이분기고진달진동위골가,인입분양정산급불동적취대기,설계8개비치체5α-환원매억제제。이불동취대적분기고진위원료,여3,6-이록달진반응제비상응분기고진달진동,재여완기련장도불동적분양정산을지중간체반응득목표화합물。결과소득목표화합물경1H-NMR、MS학인결구,병이비나웅알위양성대조약,대기진행체외활성사선,유7개화합물구유억제활성。결론활성측시현시7개목표화합물유일정적5α-환원매억제활성,기중,화합물A1화A7적억제활성교호,재3.3×10-5 mol/L수평적억제솔분별시A1(12.50%)、A7(19.64%)。
Objective To synthesize phenoxybutyric acid derivatives as 5α-reductase inhibitors and test their biological activities in vitro. Methods Eight analogues as nonsteroidal 5α-reductase inhibitors were designed and synthesized by substitution reaction of 6-(4-phenyl-piperazine-1-yl)-3(2H)-pyridazinone with phenoxybutyric acid derivatives. Results and Conclusion The structures of the compounds were characterized by 1H-NMR and MS. Biological evaluation indicated that 7 out of the 8 compounds exhibited moderate 5α-reductase inhibitory activities, especially the compounds A1 and A7 with inhibition rates reaching 12.50%and 19.64%at the concentration of 3.3×10-5 mol/L, respectively.